To help raise awareness of Alzheimer’s disease, the University of Miami Departments of Psychiatry and Behavioral Sciences and Neurology and Volunteers of America hosted a screening of the “Glen Campbell: I’ll Be Me” documentary on December 2 at the Regal Cinemas on Miami Beach.
News : 2014
W. Dalton Dietrich, Ph.D., Scientific Director of The Miami Project to Cure Paralysis and Kinetic Concepts Distinguished Chair in Neurosurgery, and Coleen Atkins, Ph.D., assistant professor of neurological surgery, have been awarded a $2 million, five-year grant by the National Institutes of Health to further develop a promising compound that could potentially help millions suffering from brain injury.
A $500,000 grant from the National Football League will enable the University of Miami Miller School of Medicine, the University of Pittsburgh School of Medicine and medical equipment manufacturer Neuro Kinetics Inc. to test the effectiveness of a diagnostic device prototype, the I-Portal® PAS goggle, for early and accurate detection of concussions.
The University of Miami’s Kessenich Family ALS Center continues to receive national recognition for the comprehensive care it provides to patients with amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease.
The University of Miami Miller School of Medicine is participating in a new, national Alzheimer’s disease clinical research study evaluating the potential benefits of an investigational medicine when taken by people with mild-to-moderate Alzheimer’s who are already being treated with donepezil (Aricept). Titled NOBLE, the trial is evaluating an investigational drug, T-817MA.
More than 300 walkers representing UHealth-University of Miami Health System joined the Miami-Dade Heart Walk Saturday, November 1, at Bayfront Park. Raising nearly $13,000 to help fund research and education sponsored by the American Heart Association, UHealth placed third among all of the companies participating in the event. A total of $366,000 was raised.
Hispanics in the U.S. at risk for cardiovascular disease also have a high prevalence of sleep apnea, which is often undiagnosed, suggesting the untreated sleep disorder can lead to diabetes and hypertension in this population, according to an analysis of the results of the landmark Hispanic Community Health Study/Study of Latinos (SOL).
Clinton Wright, M.D., M.S., Scientific Director of the Evelyn F. McKnight Brain Institute, recently became the first recipient of the Evelyn F. McKnight Endowed Chair for Learning and Memory in Aging, which will go a long way to promote research aimed at understanding how aging influences memory. The chair was established thanks to a $2 million gift to the University from the McKnight Brain Research Foundation.
The University’s WalkSafe Program and Hibiscus Elementary in Miami Gardens co-hosted Walk to School Day – an internationally and nationally celebrated event – on October 8 along with special guests to advocate for safety and health. In addition to the general festivities, the event showcased the Walksafe Poster Contest winners and special guests Sebastian the Ibis, Burnie from the Miami HEAT and Billy the Marlin.
An interdisciplinary group of researchers from the University of Miami Miller School of Medicine recently published a study that found a lack of accredited outpatient vascular testing facilities in some regions throughout the U.S., including the southern stroke belt.
The National Institute of Neurological Disorders and Stroke and the National Center for Advancing Translational Sciences, part of the National Institutes of Health, have awarded University of Miami Miller School of Medicine neurologist Michael Benatar, M.D., Ph.D., a $6.24 million cooperative agreement award to establish a Rare Diseases Clinical Research Consortium that will study amyotrophic lateral sclerosis (ALS).
Every second matters after a person has a stroke, and everyone, regardless of where they live, should have access to the critical treatment needed within a few hours of the stroke’s onset.
An international team of researchers led by geneticists at the Miller School of Medicine has discovered a completely new inherited neuromuscular disorder caused by a genetic mutation that interferes with the communication between nerves and muscles, and results in impaired muscle control.
For The Miami Project to Cure Paralysis, a Center of Excellence at the Miller School of Medicine, 2014 has been a banner year. Its researchers have been using a bench-to-bedside-and-back-again approach to more efficiently share the findings of their advanced discovery science, translational studies, clinical investigations and FDA-approved trials.
The ALS Ice Bucket Challenge is still making the rounds at the University of Miami Miller School of Medicine, after Pascal J. Goldschmidt, M.D., Senior Vice President for Medical Affairs and Dean of the Miller School and CEO of UHealth, accepted the challenge on August 20.
The “Ice Bucket Challenge” has been going viral across the nation and around the world, raising awareness and, so far, more than $10 million for the ALS Association, funding research against amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease. The Department of Neurology at the University of Miami Miller School of Medicine has been a leader in ALS research and is now joining the “Ice Bucket Challenge.”
Treatments involving neck manipulation may be associated with stroke, though it cannot be said with certainty that neck manipulation causes strokes, according to a new scientific statement published in the American Heart Association’s journal Stroke. Cervical artery dissection, a small tear in the layers of artery walls in the neck, can result in ischemic stroke if a blood clot forms after trauma and later causes blockage.
According to the American Heart Association, stroke is the fourth leading cause of death for Americans, and Hispanics face even higher risks, particularly for recurring stroke. To improve stroke prevention methods, a team of multidisciplinary physician-researchers at the Miller School of Medicine and UHealth will team up for a new five-year $1.9 million NIH grant.
For the 11th consecutive year, the University of Miami Miller School of Medicine’s Bascom Palmer Eye Institute has been ranked the nation’s best in ophthalmology by U.S. News & World Report. Bascom Palmer has received the No. 1 ranking a total of 13 times and has been in the top two since the annual rankings began 25 years ago.
Although both the incidence of stroke and the mortality rate have declined in the past decade, obesity, diabetes and lack of physical activity could reverse those trends in the future, according to two Miller School of Medicine researchers in an editorial published in the Journal of the American Medical Association (JAMA).
Taking the street drug Ecstasy could lead to a potentially fatal weakening and rupture of the artery to the spinal cord, doctors warn in a new case report published July 4 in the Journal of NeuroInterventional Surgery.
A team of Miller School researchers, collaborating with investigators at the Columbia University College of Physicians and Surgeons, has found evidence of a link between elevated levels of a hormone that regulates phosphate levels in the body and increased risk of stroke.
Researchers led by geneticists at the Miller School have discovered a new gene mutation that causes hearing loss. Their study, which focused on a large Turkish family in which six individuals have been affected by hereditary deafness, identified a mutated form of the gene FAM65B as a cause of sensorineural hearing loss.
The 8th Annual Happy Hour benefiting the ALS Recovery Fund will be held Tuesday, June 3, at Marlins Stadium, when the Miami Marlins take on the Tampa Bay Rays. A silent auction and raffle starts at 5:30 p.m. and the first pitch is at 7:10 p.m.
An audience of more than 500 healthcare and business leaders cheered as Miller School Dean Emeritus Bernard J. Fogel, M.D., received the AXA Advisors Lifetime Achievement Award at the Greater Miami Chamber of Commerce’s Health Care Heroes Awards Luncheon, held on May 20 in Jungle Island’s Treetop Ballroom. In addition, Mary Bartlett Bunge, Ph.D., won the Health Care Hero Award in the Bio-Medical category.
The American Heart Association has presented its prestigious Cor Vitae Stroke Award to Ralph L. Sacco, M.D., M.S., professor and Olemberg Chair of Neurology. Sacco received the award at the AHA’s 2014 Miami Heart & Stroke Ball, held May 17 at the Mandarin Oriental Hotel. UHealth was a Platinum Sponsor of the event.
Older migraine sufferers may be more likely to have silent brain injury, according to research led by Teshamae Monteith, M.D., assistant professor of clinical neurology and Chief of the Headache Division at the University of Miami Miller School of Medicine
An interdisciplinary team of researchers from the Miller School and Weill Cornell Medical College has found that a drug commonly given to young, obese females to treat idiopathic intracranial hypertension also has a condition-reversing effect when given to seniors of either gender who have idiopathic normal-pressure hydrocephalus (iNPH), a type of brain malfunction caused by excessive accumulation of cerebrospinal fluid.
A new Miller School research study has identified a safe and effective route for delivering stem cells to the brain, where they can potentially repair stroke-damaged tissue. “Our team found that delivering a low dose of mesenchymal stem cells (MSCs) through the carotid artery at 24 hours after stroke resulted in effective therapy for ischemic stroke in an animal model,” said lead author Dileep Yavagal, M.D.
Michal Toborek, M.D., Ph.D., Leonard M. Miller Professor of Biochemistry and Molecular Biology, received the Wybran Award at the Society of NeuroImmune Pharmacology’s 20th annual meeting in New Orleans. The highest honor bestowed by the Society, the award recognizes Toborek for his scientific contributions that have preserved and expanded the field of neuroimmune pharmacology.
When Rina Torres was diagnosed with Alzheimer’s disease in her 70s, she gradually lost her ability to communicate or recognize family members. Then she joined a University of Miami Miller School of Medicine study to test if a dietary supplement, aloe polymannose multinutrient complex (APMC), might improve her mental condition.
More than 50 corporate leaders joined UHealth and the American Heart Association at the 2014 Miami and Broward Fit Friendly Symposium, held at the UHealth Fitness and Wellness Center on April 22. The purpose of the panel event was to share health data and exchange tips for creating healthy work environments.
A group of Miller School scientists has received a $1.6 million small business award from the National Institute of Neurological Disorders and Stroke, a unit of the National Institutes of Health, to support development and clinical trials of a novel anti-inflammatory antibody treatment for human spinal cord injury.
The Miller School’s Department of Neurology is one of three institutions selected to participate in a collaborative research program to develop groundbreaking new methods of preventing, diagnosing and treating stroke, the second-leading cause of death worldwide. Funding began this month, and the department will receive $2.4 million over four years.
More than 350 guests enjoyed a dazzling dinner, dancing and entertainment at The Breakers on Saturday, March 8, for the third Palm Beach “Solving the Neurological Puzzle Gala,” which raised nearly $400,000 for the University of Miami Miller School of Medicine Department of Neurology.
Reflecting the growing recognition of the University of Miami as one of the nation’s preeminent research institutions, six of the Miller School of Medicine’s departments rose in national rankings based on the size of the research grants they received from the National Institutes of Health during the 2013 federal fiscal year. The gains were especially significant in a year that saw across-the-board reductions in NIH grants.
Registration is still available for the Department of Neurology’s annual symposium “Neurology Update and Stroke Intensive 2014” taking place February 6-8 from 7 a.m. to 4 p.m. at the Mayfair Hotel, 3000 Florida Avenue, Miami.
Carlos T. Moraes, Ph.D., professor of neurology and cell biology at the University of Miami Miller School of Medicine, was honored January 16 with the presentation of the Esther Lichtenstein Chair in Neurology. In his 20 years at the Miller School, Moraes has made significant advancements in understanding the cellular mechanisms behind degenerative neurological conditions, such as Parkinson’s and Alzheimer’s disease.